The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary safety data of the PRODIGE 81-FFCD 2101-TRIPLET-HCC trial assessing the triple combination atezolizumab-bevacizumab-ipilimumab in patients (pts) treated in systemic therapy for hepatocellular carcinoma (HCC).
 
Philippe Merle
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; Ipsen; MSD; Roche
 
Jean-Marie Peron
No Relationships to Disclose
 
Karine Le Malicot
No Relationships to Disclose
 
Meriem Guarssifi
No Relationships to Disclose
 
Thomas Aparicio
Honoraria - MSD; Pierre Fabre
Consulting or Advisory Role - Bayer; Bristol Myers Squibb; Pierre Fabre
Travel, Accommodations, Expenses - BMS; MSD Oncology; Pierre fabre; SERVIER
 
Vincent Bourgeois
No Relationships to Disclose
 
Eric Assenat
No Relationships to Disclose
 
Jean-Frédéric Blanc
Honoraria - AstraZeneca; Bayer Schering Pharma; Eisai; INCYTE; IPSEN; Roche; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; IPSEN; ROCHE; SERVIER; Taiho Pharmaceutical; Taiho Pharmaceutical
Travel, Accommodations, Expenses - AstraZeneca; IPSEN; Roche
 
Mohamed Bouattour
No Relationships to Disclose
 
Yann Touchefeu
Consulting or Advisory Role - BMS GmbH & Co. KG; Merck Serono; Pierre Fabre; Pierre Fabre; SERVIER
Travel, Accommodations, Expenses - Merck Serono; MSD Oncology; Pierre Fabre; SERVIER
 
Faiza Khemissa Akouz
Honoraria - AstraZeneca; Roche; Roche; SERVIER
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Roche; Roche; Sanofi; SERVIER
 
Eric Nguyen-Khac
No Relationships to Disclose
 
Jean-Pierre Bronowicki
No Relationships to Disclose
 
Paul Girot
No Relationships to Disclose
 
You Heng Lam
No Relationships to Disclose
 
Marion Bolliet
No Relationships to Disclose
 
Xavier Adhoute
No Relationships to Disclose
 
Julien Edeline
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Basilea; Bayer; BeiGene; Boston Scientific; Bristol-Myers Squibb; BTG; Eisai; Incyte; Ipsen; Merck Serono; MSD; Roche; SERVIER; Taiho Oncology
Research Funding - Beigene (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Exeliom Biosciences
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche
 
Jean-Charles Nault
Research Funding - Bayer (Inst); Ipsen (Inst)
Patents, Royalties, Other Intellectual Property - New Adeno-Associated Virus (AAV) Variants and Uses Thereof for Gene Therapy
 
Jean Marc Phelip
Honoraria - Amgen; AstraZeneca; Bayer; Lilly; Merck Serono; MSD Oncology; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Merck Serono; MSD Oncology; Roche; Sanofi; SERVIER
Research Funding - AstraZeneca; Merck Serono; MSD Oncology; Roche
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; Merck Serono; MSD Oncology; Roche; Sanofi; SERVIER